|
US4952584A
(en)
*
|
1986-01-11 |
1990-08-28 |
Beecham Group P.L.C. |
9H-pyrido[2,B-8]indole-3-carboxylic acid ester compounds having useful pharmaceutical activity
|
|
CA2450769A1
(en)
|
2001-06-15 |
2002-12-27 |
Vertex Pharmaceuticals Incorporated |
5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors
|
|
AUPR688101A0
(en)
|
2001-08-08 |
2001-08-30 |
Luminis Pty Limited |
Protein domains and their ligands
|
|
GB0211019D0
(en)
|
2002-05-14 |
2002-06-26 |
Syngenta Ltd |
Novel compounds
|
|
EP1518855B1
(en)
|
2002-06-28 |
2011-10-26 |
Astellas Pharma Inc. |
Diaminopyrimidinecarboxa mide derivative
|
|
MXPA05007503A
(es)
|
2003-01-17 |
2005-09-21 |
Warner Lambert Co |
Heterociclicos 2-aminopiridina sustituidos como inhibidores de proliferacion celular.
|
|
WO2005007646A1
(en)
|
2003-07-10 |
2005-01-27 |
Neurogen Corporation |
Substituted heterocyclic diarylamine analogues
|
|
GB0402653D0
(en)
|
2004-02-06 |
2004-03-10 |
Cyclacel Ltd |
Compounds
|
|
US7521457B2
(en)
|
2004-08-20 |
2009-04-21 |
Boehringer Ingelheim International Gmbh |
Pyrimidines as PLK inhibitors
|
|
FR2896503B1
(fr)
|
2006-01-23 |
2012-07-13 |
Aventis Pharma Sa |
Nouveaux derives soufres d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
|
KR20100020454A
(ko)
|
2007-06-08 |
2010-02-22 |
바이엘 크롭사이언스 소시에떼아노님 |
살진균제 헤테로사이클릴-피리미디닐-아미노 유도체
|
|
WO2009046416A1
(en)
|
2007-10-05 |
2009-04-09 |
Targegen Inc. |
Anilinopyrimidines as jak kinase inhibitors
|
|
EP2361902A4
(en)
|
2008-11-21 |
2012-04-25 |
Astellas Pharma Inc |
4,6-DIAMINONICOTINSÄUREAMIDVERBINDUNG
|
|
WO2010061971A1
(ja)
|
2008-11-28 |
2010-06-03 |
興和株式会社 |
ピリジン－３－カルボキシアミド誘導体
|
|
US8084620B2
(en)
|
2008-12-19 |
2011-12-27 |
Bristol-Myers Squibb Company |
Carbazole carboxamide compounds useful as kinase inhibitors
|
|
EP2440204B1
(en)
|
2009-06-12 |
2013-12-18 |
Bristol-Myers Squibb Company |
Nicotinamide compounds useful as kinase modulators
|
|
EP2493863B1
(en)
|
2009-10-30 |
2015-02-25 |
Janssen Pharmaceutica NV |
Phenoxy-substituted pyrimidines as opioid receptor modulators
|
|
KR20120130104A
(ko)
|
2010-02-01 |
2012-11-28 |
닛뽕 케미파 가부시키가이샤 |
Ｇｐｒ119 작동약
|
|
JP2014515029A
(ja)
|
2011-04-29 |
2014-06-26 |
アイカーン・スクール・オブ・メディシン・アト・マウント・シナイ |
キナーゼ阻害剤
|
|
CA2835963A1
(en)
|
2011-05-31 |
2012-12-06 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Amino-substituted-alkyloxy-benzo[e]pyrido[4,3-b]indole derivatives as new potent kinase inhibitors
|
|
CN104169275B
(zh)
|
2012-01-13 |
2017-06-09 |
百时美施贵宝公司 |
用作激酶抑制剂的三唑取代的吡啶化合物
|
|
ES2575604T3
(es)
|
2012-01-13 |
2016-06-29 |
Bristol-Myers Squibb Company |
Compuestos de piridilo sustituidos con tiazolilo o tiadiazolilo útiles como inhibidores cinasa
|
|
EP2802576B1
(en)
|
2012-01-13 |
2018-06-27 |
Bristol-Myers Squibb Company |
Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors
|
|
KR102233252B1
(ko)
|
2012-11-08 |
2021-03-26 |
브리스톨-마이어스 스큅 컴퍼니 |
ＩＬ-12, ＩＬ-23 및/또는 ＩＦＮα 반응의 조절제로서 유용한 알킬-아미드-치환된 피리딜 화합물
|
|
JP6215338B2
(ja)
|
2012-11-08 |
2017-10-18 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
キナーゼモジュレーターとして有用な二環式ヘテロ環置換ピリジル化合物
|
|
BR112015009850A2
(pt)
|
2012-11-08 |
2017-07-11 |
Bristol Myers Squibb Co |
compostos de piridila substituídos por heteroarila úteis como moduladores de quinase
|
|
AU2014302550A1
(en)
|
2013-06-25 |
2016-02-11 |
Bristol-Myers Squibb Company |
Carbazole carboxamide compounds useful as kinase inhibitors
|
|
TWI582077B
(zh)
|
2013-11-07 |
2017-05-11 |
必治妥美雅史谷比公司 |
作爲ＩＬ－１２、ＩＬ－２３及／或ＩＦＮα反應調節劑之經烷基－醯胺取代之吡啶化合物
|
|
WO2015088564A1
(en)
|
2013-12-13 |
2015-06-18 |
Sunovion Pharmaceuticals Inc. |
P2x4 receptor modulating compounds
|
|
UY35935A
(es)
|
2014-01-03 |
2015-06-30 |
Bristol Myers Squibb Company Una Corporación Del Estado De Delaware |
Compuestos de nicotinamida sustituida con heteroarilo como inhibidores de quinasa y moduladores de irak-4
|
|
ES2822956T3
(es)
|
2015-06-24 |
2021-05-05 |
Bristol Myers Squibb Co |
Compuestos de aminopiridina sustituidos con heteroarilo
|
|
WO2018060174A1
(de)
|
2016-09-29 |
2018-04-05 |
Bayer Pharma Aktiengesellschaft |
Substituierte benzimidazole, pharmazeutische präparate diese enthaltend, sowie deren verwendung zur herstellung von arzneimitteln
|
|
CN110475777B
(zh)
*
|
2017-03-30 |
2022-04-15 |
豪夫迈·罗氏有限公司 |
用于治疗和预防细菌感染的新吡啶并[2,3-b]吲哚化合物
|